To achieve malaria elimination on the continent, Africans need to own the agenda.
L’expertise universitaire, l’exigence journalistique
Articles sur Science and innovation for development
Affichage de 41 à 60 de 220 articles
The successful development of an effective vaccine against the deadliest form of malaria that is most common in sub-Saharan Africa is indeed a major achievement.
The WHO and the manufacturers of the vaccine will be rallying countries, particularly those with high malaria burdens, to adopt the vaccine.
Smallholder rice farmers in Ghana should be supported by the government to access finance needed to adopt modern technologies for greater productivity.
Making vaccines in South Africa by building on the foundation that’s been laid is possible. But only if substantial and sustained investment in human resources and infrastructure becomes a reality.
Sexually transmitted infections and bacterial vaginosis can provide ideal conditions for HIV infection in women. A new test aims to detect these conditions even when women don’t show symptoms.
Current approaches to expand renewable energy in Ghana are not inclusive of the rural poor.
Malaria control must move away from relying too much on insecticides to more innovative and sustainable options. Genetic programming of mosquitoes is one.
Potential benefits of human genome editing include new ways to diagnose, treat and prevent genetic disorders. But there’s a significant gap in regulation.
More funding is needed to galvanise
Nigeria’s health system as medical research is not well funded.
We’ve made advances towards delivering new devices to empower even people with basic medical knowledge to administer malaria tests in the field.
Discovery of a new antibiotic compound from a Nigerian environment is good news for researchers in this field.
The decision is supported by the government’s policy environment in recent years. This has aimed to increase innovation, and views technology as a way to achieve this.
Stronger agricultural R&D systems will enable agriculture to power Africa’s transformation.
Policymakers need to make sense of the data so as to predict and manage what’s happening. To address this need, we developed a visualisation tool to track and predict country-level COVID-19 cases.
BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
Machine learning offers improved access to affordable testing and quality of care for those who are unaware of their hepatitis B status.
Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
The rule, which previously acted as the upper time limit on human embryo research, has been dropped, paving the way for research on older human embryos.
Entrepreneurs can create entirely new ways of providing goods and services if they’re adequately trained to take advantage of technological advances.
Les contributeurs les plus fréquents
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
-
Professor of the Practice of International Development, Harvard Kennedy School
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Tutorial Fellow, School of Medicine, University of Nairobi, University of Nairobi
-
Associate Professor at the University of Pretoria and Co-ordinator of the South African SDG Hub, University of Pretoria
-
Post Doctoral Fellow, University of KwaZulu-Natal
-
Professor in Biochemistry, Genetics and Microbiology, and Professor at Future Africa, University of Pretoria, University of Pretoria
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Director, Institute for Cellular and Molecular Medicine & SAMRC Extramural Unit for Stem Cell Research & Therapy, University of Pretoria
-
Director of Science, Ifakara Health Institute
-
Head of the Division of Pulmonology, University of Cape Town
-
Fellow, Nigerian Academy of Science
